-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on IDEAYA Biosciences, Raises Price Target to $57

Benzinga·09/09/2026 13:12:04
Listen to the news
Guggenheim analyst Paul Jeng maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and raises the price target from $54 to $57.